2017 Q1 Form 10-Q Financial Statement
#000156459017010548 Filed on May 11, 2017
Income Statement
| Concept | 2017 Q1 | 2016 Q4 | 2016 Q1 |
|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 |
| YoY Change | |||
| Cost Of Revenue | |||
| YoY Change | |||
| Gross Profit | |||
| YoY Change | |||
| Gross Profit Margin | |||
| Selling, General & Admin | $4.010M | $3.380M | $4.120M |
| YoY Change | -2.67% | -11.29% | 76.82% |
| % of Gross Profit | |||
| Research & Development | $9.204M | $9.140M | $12.00M |
| YoY Change | -23.3% | -27.86% | 82.01% |
| % of Gross Profit | |||
| Depreciation & Amortization | $226.0K | $220.0K | $233.0K |
| YoY Change | -3.0% | -4.35% | 11.48% |
| % of Gross Profit | |||
| Operating Expenses | $13.21M | $12.53M | $16.12M |
| YoY Change | -18.02% | -24.0% | 80.62% |
| Operating Profit | -$13.21M | -$16.12M | |
| YoY Change | -18.02% | 80.62% | |
| Interest Expense | -$60.00K | ||
| YoY Change | 50.0% | ||
| % of Operating Profit | |||
| Other Income/Expense, Net | -$194.0K | $28.00K | |
| YoY Change | -792.86% | -118.79% | |
| Pretax Income | -$13.41M | -$12.62M | -$16.09M |
| YoY Change | -16.66% | -23.47% | 77.4% |
| Income Tax | -$50.00K | ||
| % Of Pretax Income | |||
| Net Earnings | -$13.41M | -$12.57M | -$16.09M |
| YoY Change | -16.67% | -23.81% | 77.35% |
| Net Earnings / Revenue | |||
| Basic Earnings Per Share | |||
| Diluted Earnings Per Share | -$7.888M | -$7.438M | -$9.521M |
| COMMON SHARES | |||
| Basic Shares Outstanding | 23.75M | 23.72M | 23.68M |
| Diluted Shares Outstanding |
Balance Sheet
| Concept | 2017 Q1 | 2016 Q4 | 2016 Q1 |
|---|---|---|---|
| SHORT-TERM ASSETS | |||
| Cash & Short-Term Investments | $61.93M | $72.15M | $86.00M |
| YoY Change | -27.98% | -24.48% | 57.8% |
| Cash & Equivalents | $28.90M | $38.39M | $54.10M |
| Short-Term Investments | $33.03M | $33.76M | $31.90M |
| Other Short-Term Assets | $1.800M | $2.600M | $1.600M |
| YoY Change | 12.5% | 8.33% | 128.57% |
| Inventory | |||
| Prepaid Expenses | |||
| Receivables | |||
| Other Receivables | |||
| Total Short-Term Assets | $63.80M | $74.80M | $87.60M |
| YoY Change | -27.17% | -23.63% | 58.78% |
| LONG-TERM ASSETS | |||
| Property, Plant & Equipment | $1.600M | $1.421M | $1.800M |
| YoY Change | -11.11% | -20.75% | -2.12% |
| Goodwill | |||
| YoY Change | |||
| Intangibles | |||
| YoY Change | |||
| Long-Term Investments | $4.000M | $25.60M | |
| YoY Change | -86.58% | ||
| Other Assets | $300.0K | $333.0K | $100.0K |
| YoY Change | 200.0% | 182.2% | -96.55% |
| Total Long-Term Assets | $1.900M | $5.724M | $27.50M |
| YoY Change | -93.09% | -81.96% | 480.66% |
| TOTAL ASSETS | |||
| Total Short-Term Assets | $63.80M | $74.80M | $87.60M |
| Total Long-Term Assets | $1.900M | $5.724M | $27.50M |
| Total Assets | $65.70M | $80.52M | $115.1M |
| YoY Change | -42.92% | -37.9% | 92.14% |
| SHORT-TERM LIABILITIES | |||
| YoY Change | |||
| Accounts Payable | $1.200M | $2.606M | $5.900M |
| YoY Change | -79.66% | -32.7% | 86.24% |
| Accrued Expenses | $4.200M | $5.450M | $3.600M |
| YoY Change | 16.67% | 18.61% | 36.11% |
| Deferred Revenue | |||
| YoY Change | |||
| Short-Term Debt | $0.00 | $0.00 | $0.00 |
| YoY Change | |||
| Long-Term Debt Due | $1.094M | $339.0K | $3.400M |
| YoY Change | -67.82% | -89.93% | -34.62% |
| Total Short-Term Liabilities | $6.549M | $8.525M | $13.19M |
| YoY Change | -50.35% | -29.82% | 14.26% |
| LONG-TERM LIABILITIES | |||
| Long-Term Debt | $8.480M | $9.198M | $900.0K |
| YoY Change | 842.22% | 417.91% | -79.07% |
| Other Long-Term Liabilities | $0.00 | $557.0K | |
| YoY Change | -100.0% | 46.58% | |
| Total Long-Term Liabilities | $8.480M | $9.198M | $557.0K |
| YoY Change | 1422.44% | 291.9% | 46.58% |
| TOTAL LIABILITIES | |||
| Total Short-Term Liabilities | $6.549M | $8.525M | $13.19M |
| Total Long-Term Liabilities | $8.480M | $9.198M | $557.0K |
| Total Liabilities | $15.03M | $17.72M | $13.75M |
| YoY Change | 9.32% | 22.27% | 15.29% |
| SHAREHOLDERS EQUITY | |||
| Retained Earnings | -$229.4M | -$216.0M | -$174.2M |
| YoY Change | 31.67% | 36.59% | 46.12% |
| Common Stock | $280.2M | $278.9M | $274.7M |
| YoY Change | 2.0% | 2.02% | 1194.6% |
| Preferred Stock | |||
| YoY Change | |||
| Treasury Stock (at cost) | |||
| YoY Change | |||
| Treasury Stock Shares | |||
| Shareholders Equity | $50.71M | $62.80M | $100.4M |
| YoY Change | |||
| Total Liabilities & Shareholders Equity | $65.74M | $80.52M | $115.1M |
| YoY Change | -42.9% | -37.9% | 92.18% |
Cashflow Statement
| Concept | 2017 Q1 | 2016 Q4 | 2016 Q1 |
|---|---|---|---|
| OPERATING ACTIVITIES | |||
| Net Income | -$13.41M | -$12.57M | -$16.09M |
| YoY Change | -16.67% | -23.81% | 77.35% |
| Depreciation, Depletion And Amortization | $226.0K | $220.0K | $233.0K |
| YoY Change | -3.0% | -4.35% | 11.48% |
| Cash From Operating Activities | -$13.89M | -$11.69M | -$12.49M |
| YoY Change | 11.21% | 18.8% | 98.57% |
| INVESTING ACTIVITIES | |||
| Capital Expenditures | $262.0K | -$50.00K | $314.0K |
| YoY Change | -16.56% | -54.55% | 155.28% |
| Acquisitions | |||
| YoY Change | |||
| Other Investing Activities | $4.660M | $8.650M | $14.71M |
| YoY Change | -68.32% | 115.17% | 654.36% |
| Cash From Investing Activities | $4.400M | $8.600M | $14.39M |
| YoY Change | -69.42% | 119.95% | 686.34% |
| FINANCING ACTIVITIES | |||
| Cash Dividend Paid | |||
| YoY Change | |||
| Common Stock Issuance & Retirement, Net | $1.000K | $11.00K | |
| YoY Change | -90.91% | -84.06% | |
| Debt Paid & Issued, Net | $838.0K | ||
| YoY Change | |||
| Cash From Financing Activities | 0.000 | 7.150M | -830.0K |
| YoY Change | -100.0% | -755.96% | -101.84% |
| NET CHANGE | |||
| Cash From Operating Activities | -13.89M | -11.69M | -12.49M |
| Cash From Investing Activities | 4.400M | 8.600M | 14.39M |
| Cash From Financing Activities | 0.000 | 7.150M | -830.0K |
| Net Change In Cash | -9.490M | 4.060M | 1.070M |
| YoY Change | -986.92% | -157.83% | -97.37% |
| FREE CASH FLOW | |||
| Cash From Operating Activities | -$13.89M | -$11.69M | -$12.49M |
| Capital Expenditures | $262.0K | -$50.00K | $314.0K |
| Free Cash Flow | -$14.15M | -$11.64M | -$12.80M |
| YoY Change | 10.53% | 19.63% | 99.66% |
Facts In Submission
| Frame | Concept Type | Concept / XBRL Key | Value | Unit |
|---|---|---|---|---|
| CY2017Q1 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
280134000 | |
| CY2016Q4 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
278832000 | |
| CY2016Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
| CY2016Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
150000000 | |
| CY2016Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
23744832 | |
| CY2016Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
23744832 | |
| CY2017Q1 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
4007000 | |
| CY2017Q1 | us-gaap |
Operating Expenses
OperatingExpenses
|
13211000 | |
| CY2016Q1 | us-gaap |
Operating Expenses
OperatingExpenses
|
16115000 | |
| CY2017Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-13211000 | |
| CY2016Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-16115000 | |
| CY2017Q1 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-194000 | |
| CY2016Q1 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
28000 | |
| CY2017Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-13405000 | |
| CY2016Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-16087000 | |
| CY2017Q1 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.56 | |
| CY2016Q1 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.68 | |
| CY2017Q1 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
23739057 | |
| CY2016Q1 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
23631133 | |
| CY2017Q1 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
| CY2016Q4 | us-gaap |
Long Term Debt Current
LongTermDebtCurrent
|
339000 | |
| CY2016Q4 | us-gaap |
Long Term Debt Noncurrent
LongTermDebtNoncurrent
|
9198000 | |
| CY2016Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
||
| CY2017Q1 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
||
| CY2017Q1 | us-gaap |
Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
|
33034000 | |
| CY2016Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
24000 | |
| CY2016Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-215979000 | |
| CY2016Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
62801000 | |
| CY2017Q1 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
6549000 | |
| CY2017Q1 | us-gaap |
Long Term Debt Noncurrent
LongTermDebtNoncurrent
|
8480000 | |
| CY2016Q4 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
-76000 | |
| CY2017Q1 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
65735000 | |
| CY2017Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
50706000 | |
| CY2017Q1 | us-gaap |
Long Term Debt Current
LongTermDebtCurrent
|
1094000 | |
| CY2016Q4 | us-gaap |
Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
|
4002000 | |
| CY2017Q1 | us-gaap |
Common Stock Value
CommonStockValue
|
24000 | |
| CY2017Q1 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
-68000 | |
| CY2017Q1 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-229384000 | |
| CY2016Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
80524000 | |
| CY2017Q1 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
150000000 | |
| CY2017Q1 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
23780976 | |
| CY2017Q1 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
23780976 | |
| CY2017Q1 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
9204000 | |
| CY2016Q1 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
12000000 | |
| CY2016Q1 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
4115000 | |
| CY2016Q1 | us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
152000 | |
| CY2017Q1 | us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
8000 | |
| CY2016Q1 | us-gaap |
Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
|
24700000 | |
| CY2017Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
|
4399000 | |
| CY2017Q1 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-13397000 | |
| CY2016Q1 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-15935000 | |
| CY2017Q1 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
226000 | |
| CY2016Q1 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
233000 | |
| CY2017Q1 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
1277000 | |
| CY2016Q1 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
1280000 | |
| CY2017Q1 | us-gaap |
Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
|
-37000 | |
| CY2016Q1 | us-gaap |
Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
|
54000 | |
| CY2017Q1 | us-gaap |
Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
|
-74000 | |
| CY2016Q1 | us-gaap |
Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
|
-264000 | |
| CY2017Q1 | life |
Increase Decrease In Deferred Rent Credit
IncreaseDecreaseInDeferredRentCredit
|
-81000 | |
| CY2016Q1 | life |
Increase Decrease In Deferred Rent Credit
IncreaseDecreaseInDeferredRentCredit
|
-76000 | |
| CY2017Q1 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
-776000 | |
| CY2016Q1 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
-858000 | |
| CY2017Q1 | us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
-2742000 | |
| CY2016Q1 | us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
983000 | |
| CY2017Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
|
-13912000 | |
| CY2016Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
|
-12491000 | |
| CY2017Q1 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
262000 | |
| CY2016Q1 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
314000 | |
| CY2017Q1 | us-gaap |
Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
|
11489000 | |
| CY2016Q1 | us-gaap |
Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
|
9994000 | |
| CY2017Q1 | us-gaap |
Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
|
16150000 | |
| CY2016Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
|
14392000 | |
| CY2017Q1 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
25000 | |
| CY2016Q1 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
11000 | |
| CY2016Q1 | us-gaap |
Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
|
838000 | |
| CY2017Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
|
25000 | |
| CY2016Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
|
-827000 | |
| CY2017Q1 | us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
-9488000 | |
| CY2016Q1 | us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
1074000 | |
| CY2015Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
53025000 | |
| CY2016Q1 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
54099000 | |
| CY2017Q1 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<div> <p style="margin-bottom:6pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Use of Estimates</p> <p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;">Our consolidated financial statements are prepared in accordance with GAAP. The preparation of our consolidated financial statements requires us to make estimates and assumptions that impact the reported amounts of assets, liabilities and expenses and the disclosure of contingent assets and liabilities in our consolidated financial statements and accompanying notes. The most significant estimates in our consolidated financial statements relate to the fair value of equity issuances and awards, and clinical trials and research and development expense accruals. Although these estimates are based on our knowledge of current events and actions we may undertake in the future, actual results may ultimately differ materially from these estimates and assumptions.</p></div> | |
| CY2017Q1 | life |
Cash And Cash Equivalents And Available For Sale Investments
CashAndCashEquivalentsAndAvailableForSaleInvestments
|
61900000 | |
| CY2017Q1 | us-gaap |
Weighted Average Number Of Shares Common Stock Subject To Repurchase Or Cancellation
WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation
|
9039 | |
| CY2016Q1 | us-gaap |
Weighted Average Number Of Shares Common Stock Subject To Repurchase Or Cancellation
WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation
|
44136 | |
| CY2017Q1 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
4878731 | |
| CY2016Q1 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
3786103 | |
| CY2017Q1 | us-gaap |
Available For Sale Securities Continuous Unrealized Loss Position Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue
|
26521000 | |
| CY2017Q1 | us-gaap |
Available For Sale Securities Continuous Unrealized Loss Position Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLoss
|
20000 | |
| CY2017Q1 | us-gaap |
Available For Sale Securities In Unrealized Loss Positions Qualitative Disclosure Number Of Positions Less Than One Year
AvailableForSaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsLessThanOneYear
|
15 | |
| CY2017Q1 | life |
Available For Sale Securities In Gross Unrealized Loss Position Maturities Term Maximum
AvailableForSaleSecuritiesInGrossUnrealizedLossPositionMaturitiesTermMaximum
|
P12M | |
| CY2017Q1 | us-gaap |
Debt Instrument Payment Terms
DebtInstrumentPaymentTerms
|
(i) $10.0 million which was funded on November 18, 2016; (ii) $5.0 million may be drawn down by us at any time before the earlier of June 30, 2017 or an event of default, at our discretion, subject to achievement of certain financial and clinical milestones; and (iii) $5.0 million may be drawn down by us any time after June 30, 2017 and before the earlier of December 31, 2017 or an event of default, at our discretion, subject to achievement of certain milestones specified for the second tranche and additional financial and clinical milestones. | |
| CY2017Q1 | life |
Lease Agreement Extended Term
LeaseAgreementExtendedTerm
|
P2Y | |
| CY2017Q1 | life |
Noncancelable Operating Leases Term Of Extension
NoncancelableOperatingLeasesTermOfExtension
|
2019-05 | |
| CY2017Q1 | us-gaap |
Lease And Rental Expense
LeaseAndRentalExpense
|
200000 | |
| CY2016Q1 | us-gaap |
Lease And Rental Expense
LeaseAndRentalExpense
|
100000 | |
| CY2016Q2 | life |
Sublease Agreement Commenced Date
SubleaseAgreementCommencedDate
|
2016-08 | |
| CY2016Q2 | life |
Sublease Agreement Expiration Date
SubleaseAgreementExpirationDate
|
2017-06 | |
| CY2017Q1 | us-gaap |
Operating Leases Future Minimum Payments Remainder Of Fiscal Year
OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear
|
683000 | |
| CY2017Q1 | us-gaap |
Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
|
773000 | |
| CY2017Q1 | us-gaap |
Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
|
293000 | |
| CY2017Q1 | us-gaap |
Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
|
1749000 | |
| CY2017Q1 | us-gaap |
Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
|
6282612 | |
| CY2016Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
4014988 | |
| CY2017Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
765719 | |
| CY2017Q1 | us-gaap |
Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
|
795 | |
| CY2017Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
|
122894 | |
| CY2017Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
4657018 | |
| CY2016Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
6.73 | |
| CY2017Q1 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
3.29 | |
| CY2017Q1 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
|
1.01 | |
| CY2017Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
|
6.98 | |
| CY2017Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
6.16 |
